Imnovid (previously Pomalidomide Celgene)
Active substance: pomalidomide
Pomalidomide
Centralised EU authorisationActive
Marketing holder: Bristol-Myers Squibb Pharma EEIG
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 15 |
|
| US 47 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-35b3-73a1-af34-deb6609f577f,01a120c3-43d0-747a-bcea-9d8b99ee1a91,01a120c3-4a34-7227-a88c-f0111801eeae,01a120c3-4f0d-7b0d-9829-731d69f5f11e,01a120c3-5259-74dd-8056-e13b9173dd53;count=14 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3be3-7094-a5fe-1a47653f3cc4,01a1208c-5e1b-792b-b01a-66efa61ac80a,01a1208c-80d4-7283-ba25-d6e693330646,01a1208c-8104-75b8-9bd9-d8ff40e91c43,01a1208d-0645-74c2-a04a-a2ae7eed9e57;count=47 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/002682
- Registration status
- Active
- ATC code
- L04AX06
- product · EMA · EMEA/H/C/002682 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002682 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002682 · Verified 2026-10-09